---
title: StemExpress vs Ubigene Biosciences
slug_a: stemexpress
slug_b: ubigene
site: cro
review_signal_gate: closed
canonical_path: /compare/stemexpress/ubigene
generated_by: BioBM Editorial AI
---

# StemExpress vs Ubigene Biosciences

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

StemExpress (stemexpress) is listed for cro. StemExpress, now part of CGT Global, supplies biospecimens and cellular starting materials for cell and gene therapy research, including GMP-grade leukopaks, PBMCs, bone marrow, and cord blood for clinical and research applications.

Services: 1. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in modalities (2).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Ubigene Biosciences (ubigene) is listed for cro. Ubigene provides CRISPR gene editing services including knockout, knockin, and point mutation cell lines, plus CRISPR library screening and stable cell line generation for research and development.

Services: 4. Modalities: 1. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (4).

Review summary: Review summary withheld until site-level review gate opens.